Kumpulan Info tentang,
UNIVERSITAS SURABAYA
| No | Source Title | CiteScore | Quartile | Publisher | Highest percentile | Citations 2021-24 | Documents 2021-24 |
|---|---|---|---|---|---|---|---|
| 1021 | Pharmacogenomics Journal | 6.3 | Q2 | Springer Nature | 69.0% 100/321 Pharmacology | 1083 | 171 |
| 1022 | Biomolecules and Therapeutics | 6.2 | Q2 | Korean Society of Applied Pharmacology | 68.0% 102/321 Pharmacology | 1799 | 290 |
| 1023 | Journal of Pharmacology and Experimental Therapeutics | 6.3 | Q2 | Elsevier | 68.0% 101/321 Pharmacology | 3450 | 552 |
| 1024 | Chemical Biology and Drug Design | 5.6 | Q2 | John Wiley & Sons | 67.0% 70/212 Organic Chemistry | 4585 | 821 |
| 1025 | RSC Medicinal Chemistry | 5.6 | Q2 | Royal Society of Chemistry | 67.0% 68/212 Organic Chemistry | 4591 | 814 |
| 1026 | Experimental and Clinical Psychopharmacology | 5 | Q2 | American Psychological Association | 67.0% 190/580 Psychiatry and Mental Health | 1838 | 369 |
| 1027 | Microbial Drug Resistance | 6.2 | Q2 | Mary Ann Liebert | 67.0% 104/321 Pharmacology | 2758 | 446 |
| 1028 | Fundamental and Clinical Pharmacology | 5.3 | Q2 | John Wiley & Sons | 66.0% 94/275 Pharmacology (medical) | 2050 | 390 |
| 1029 | Journal of Food and Drug Analysis | 4.8 | Q2 | National Laboratories of Foods and Drugs | 66.0% 135/404 Food Science | 905 | 187 |
| 1030 | Basic and Clinical Pharmacology and Toxicology | 5.9 | Q2 | John Wiley & Sons | 66.0% 109/321 Pharmacology | 2838 | 484 |
| 1031 | Current Pharmaceutical Design | 5.9 | Q2 | Bentham Science Publishers | 66.0% 108/321 Pharmacology | 6698 | 1130 |
| 1032 | Anti-Cancer Agents in Medicinal Chemistry | 5.8 | Q2 | Bentham Science Publishers | 65.0% 110/321 Pharmacology | 4398 | 753 |
| 1033 | Journal of Clinical Pharmacology | 5.1 | Q2 | John Wiley & Sons | 64.0% 98/275 Pharmacology (medical) | 3261 | 641 |
| 1034 | Critical Reviews in Therapeutic Drug Carrier Systems | 5.4 | Q2 | Begell House | 64.0% 66/185 Pharmaceutical Science | 380 | 71 |
| 1035 | Trends in Phytochemical Research | 3.4 | Q2 | OICC Press | 64.0% 190/534 Plant Science | 317 | 93 |
| 1036 | Pharmacology | 5.7 | Q2 | Karger | 64.0% 115/321 Pharmacology | 1278 | 226 |
| 1037 | Immunopharmacology and Immunotoxicology | 5.7 | Q2 | Taylor & Francis | 64.0% 113/321 Pharmacology | 2062 | 360 |
| 1038 | Journal of Ocular Pharmacology and Therapeutics | 3.5 | Q2 | Mary Ann Liebert | 63.0% 52/141 Ophthalmology | 1036 | 295 |
| 1039 | Clinical and Experimental Pharmacology and Physiology | 5.5 | Q2 | John Wiley & Sons | 63.0% 43/117 Physiology (medical) | 2483 | 452 |
| 1040 | Open Medicinal Chemistry Journal | 5 | Q2 | Bentham Science Publishers | 62.0% 70/185 Pharmaceutical Science | 105 | 21 |
| 1041 | Drug Development and Industrial Pharmacy | 5 | Q2 | Taylor & Francis | 62.0% 69/185 Pharmaceutical Science | 2048 | 407 |
| 1042 | Records of Natural Products | 3.2 | Q2 | ACG Publications | 62.0% 201/534 Plant Science | 964 | 298 |
| 1043 | Molecular Pharmacology | 5.5 | Q2 | Elsevier | 62.0% 121/321 Pharmacology | 1495 | 271 |
| 1044 | CNS and Neurological Disorders - Drug Targets | 5.5 | Q2 | Bentham Science Publishers | 62.0% 120/321 Pharmacology | 1925 | 347 |
| 1045 | Expert Opinion on Emerging Drugs | 4.7 | Q2 | Taylor & Francis | 62.0% 105/275 Pharmacology (medical) | 545 | 115 |
| 1046 | Journal of Clinical Pharmacy and Therapeutics | 4.8 | Q2 | John Wiley & Sons | 62.0% 104/275 Pharmacology (medical) | 2796 | 586 |
| 1047 | Journal of Asian Natural Products Research | 3.1 | Q2 | Taylor & Francis | 61.0% 44/112 Complementary and Alternative Medicine | 1541 | 497 |
| 1048 | Pharmacology Biochemistry and Behavior | 5.2 | Q2 | Elsevier | 61.0% 35/90 Behavioral Neuroscience | 2385 | 462 |
| 1049 | Current Molecular Pharmacology | 5.5 | Q2 | KeAi Communications Co. | 61.0% 124/321 Pharmacology | 1715 | 312 |
| 1050 | Journal of Immunotherapy | 5.5 | Q2 | Wolters Kluwer Health | 61.0% 123/321 Pharmacology | 1073 | 195 |